You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Kjell Strandberg

Senior Advisor at HealthCap AB
Overview
Relationships
Paths
Memberships
Career History
Boards & Committees

Kjell Strandberg

Senior Advisor at HealthCap AB

Overview

Age
79 (Born 1938)
Board Seats
3
Number of Relationships
This person is connected to 138 people.

Relationships See Details


Founding Partner at HealthCap AB

Founding Partner at HealthCap AB

Senior Advisor at HealthCap AB

Executive Chairman at Orexo AB

Founding Partner at HealthCap AB

Co-Founder at AbClon, Inc.

Chief Executive Officer & Director at Monica Caneman Konsult AB

Director at TXP Pharma GmbH

Chairman at Ferrosan Medical Devices

President & Chairman-Trustees Council at British Pharmacological Society
See 128 more listings with RelSci Professional.

Paths to Kjell Strandberg

Kjell Strandberg
You
Connections via Relationship Science
Kjell Strandberg
Sync your contacts to see how you can connect with Kjell Strandberg.

Memberships

Member
Current
Founded in 1919 and was the first engineering science academy in the world.

Career History

Chairman, Chief Executive Officer & Professor-Pharmacotherapeutics
Current
Senior Advisor
Current
Healthcap is an active, long-term manager which invests in pharmaceutical, biotechnology and medical technology companies globally. As a multi-stage fund, the firm provides and participates in financing through all stages of company evolution. Their funds have no geographic restrictions.Healthcap's main investment style is to be lead investor and the firm acts predominantly as an influential minority investor, seeking to invest in the commercialization of innovations in medical science where they believe that the structural changes taking place in the pharmaceutical industry create significant opportunities for knowledgeable investors to achieve high financial returns.The firm partners with investee companies and founders, seeking board representation to assist with strategy formulation in the areas of science, business development and finance. They encourage substantial ownership by entrepreneurs and scientific founders and insist on implementing employee equity ownership programs to attract and reward key personnel.Healthcap's in-house science team evaluates the scientific merits of investment proposals and their in-house transaction team structures the transactions. The firm invests independently or in partnership with other investor groups.

Boards & Committees

Corporate Boards ▾
Chairman
Current
Director
2003 - 2012
Orexo AB engages in the development of pharmaceuticals based on innovative drug delivery technologies. Its focuses on the treatment of opioid dependence. It distributes its products under the following brands: Zubsolv, Abstral, and Edluar. The company was founded by Thomas Lundqvist, Anders Pettersson, and Lars Christer Nyström on November 18, 1994 and is headquartered in Uppsala, Sweden.
Director
Prior
Creative Antibiotics AB is engaged in the development of antibacterial agents. It was established to commercialise research, principally at Umeå University, Karolinska Institute and Stockholm University. The company was founded in 2000 and is headquartered in Umeå, Sweden.

Other Affiliations

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial ➤
Still not convinced? Check out our full listing of features here.